v3.26.1
Stock-based Compensation (Tables)
 6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Option Activity
The following table summarizes the Company’s option activity for the six months ended June 30, 2026 (in thousands, except exercise price and contractual life data):
Number
Outstanding 		Weighted
Average
Exercise
Price per
Share		Weighted
Average
Remaining
Contractual Life (Years)
Balance as of January 1, 20267,063 $4.11 2.6
Granted196 9.82 9.7
Exercised(1,206)3.52 0.0
Forfeited(188)8.95 0.0
Balance as of June 30, 20265,865 4.26 2.6
Vested and exercisable as of June 30, 20263,460 $3.34 2.2
Schedule of Grant-Date Fair Value of Stock Options Granted
The following table presents the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted during the three and six months ended June 30, 2026 and 2025:
Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
Exercise price
$7.06 - 12.24
$7.06 - 12.24
$7.06 - 12.24
$1.00 - 14.34
Risk-free interest rate
3.8 - 4.3%
3.4 - 4.3%
3.4 - 4.3%
4.0 - 4.2%
Expected volatility
125.7 - 130.1%
130 - 138%
125.7 - 136.2%
130.0 - 138.0%
Expected dividend yield0%0%0%0%
Expected life of options (in years)105105
Schedule of Exercise Price Range
The following table summarizes the exercise price range as of June 30, 2026 (in thousands, except exercise price data):
Exercise PriceOutstanding OptionsExercisable Options
$0.00 - 1.00
554 419 
$1.00 - 2.00
2,660 1,221 
$2.00 - 3.00
1,098 1,098 
$3.00 - 6.00
110 30 
$6.00 - 8.00
537 505 
$8.00 - 12.00
268 77 
$12.00 - 22.00
638 110 
5,865 3,460 
Schedule of Activity for Restricted Stock The following table summarizes the Company’s activity for restricted stock tied to vesting schedules for the three and six months ended June 30, 2026 (in thousands):
Number OutstandingWeighted Average
Fair Value
Unvested as of December 31, 2025700 $5.6 
Granted438 10.1 
Vested(55)6.8 
Forfeited(6)7.0 
Unvested as of June 30, 20261,077 $5.3 
Schedule of Stock-Based Compensation Expense Related to Common Stock Options and Restricted Shares of Common Stock
The Company recognized stock-based compensation expense related to common stock options and restricted shares of common stock in the following expense categories of its condensed consolidated statements of operations (in thousands):
Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
Research and development$840 $467 $1,596 $964 
Sales and marketing82 31 144 91 
General and administrative837 1,279 1,265 2,109 
Total stock-based compensation$1,759 $1,777 $3,005 $3,164